Spermatogenesis and fertility outcome in male hypogonadotrophic hypogonadism

References

• Baker, H. W. G. (2000). Management of male infertility. Bailliére's Clinical. Endocrinology and Metabolism, 14, 409–422.
   Google Scholar
• Bakircioglu, M. E., Erden, H. F., Ciray, H. N., Bayazit, N., Bahçeci, M. (2007). Gonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadism. Reproductive BioMedicine Online, 15, 156–160.
   PubMed Web of Science ®Google Scholar
• Bhagavath, B., Podolsky, R. H., Ozata, M., Bolu, E., Bick, D.P., Kulharya, A., et al (2006). Clinical and molecular characterization of a large sample of patients with hypogonadotrophic hypogonadism. Fertility and Sterility, 85, 706–713.
   PubMed Web of Science ®Google Scholar
• Boivin, J., Bunting, L., Collins, J. A., Nygren, K. G. (2007). International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Human Reproduction, 22, 1506–1512.
   PubMed Web of Science ®Google Scholar
• Bouloux, P-M., Nieschlag, E., Burger, H., Skakkebaek, N. E., Wu, F. C. W., Handelsman, D. J., et al (2003). Induction of spermatogenesis by recombinant folliclestimulating hormone (Puregon) in hypogonadotrophic azoospermic men who failed to respond to human chorionic gonadotrophin alone. Journal of Andrology, 24, 132–139.
   Google Scholar
• Comhaire, F. H., de Kretser, D. M., Farley, I. M., Rowe, P. J. (1987). Towards more objectivity in diagnosis and management of male infertility. International Journal of Andrology, 7(Suppl.1), 1–53.
   Google Scholar
• European Metrodin HP Study Group. (1998). Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertility and Sterility, 70, 256–262.
   PubMed Web of Science ®Google Scholar
• Fahmy, I., Kamal, A., Shamloul, R., Mansour, R., Serour, G., Aboulghar, M. (2004). ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy. Human Reproduction, 19, 1558–1561.
   PubMed Web of Science ®Google Scholar
• Fedder, J., Carlsen, E., Sønksen, J. (2007). Dansk fertilitetsselskap. Kliniske guidelines. Behandling ved mandlig infertilitet. Available from: http://www.fertilitetsselskab.dk/guidelines.asp. Published 20.10.2007.
   Google Scholar
• Finkel, D. M., Phillips, J. L., Snyder, P. J. (1985). Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. New England Journal of Medicine, 313, 651–655.
   PubMed Web of Science ®Google Scholar
• Huhtaniemi, I., Alevizaki, M. (2006). Gonadotrophin resistance. Best Practice & Research Clinical Endocrinology & Metabolism, 50, 561–576.
   Google Scholar
• Jockenhövel, F. (2004). Hypogonadism in men. In: Male hypogonadism. Bremen: UNI-MED Verlag AG, pp 30–43.
   Google Scholar
• Jones, T. H., Darne, J. F. (1993). Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism. Clinical Endocrinology, 338, 203–208.
   Google Scholar
• Layman, L. (2007). Hypogonadotrophic hypogonadism. Endocrinology & Metabolism Clinics of North America, 36, 283–296.
   PubMedGoogle Scholar
• Liu, P.Y., Handelsman, G. J. (2003). The present and future state of hormonal treatment for male infertility. Human Reproduction Update, 9, 9–23.
   PubMed Web of Science ®Google Scholar
• Liu, P. Y., Turner, L., Ruchford, D., McDonald, J., Baker, H. M. G., Conway, A. J., et al (1999). Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Human Reproduction, 14, 1540–1545.
   PubMed Web of Science ®Google Scholar
• Liu, P. Y., Gebski, V. J., Turner, L., Conway, A. J., Wishart, S. M., Handelsman, D. J. (2002). Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Human Reproduction, 17, 625–633.
   PubMed Web of Science ®Google Scholar
• Liu, P. Y., Baker, G. H. W., Jayadev, V., Zacharin, M., Conway, A. J., Handelsman, D. J. (2009). Induction of spermatogenesis and fertility during gonadotrophin treatment of gonadotrophin-deficient infertile men: predictors of fertility outcome. Journal of Clinical and Endocrinology Metabolism, 94, 801–808.
   PubMed Web of Science ®Google Scholar
• MacColl, G., Quinton, R., Bouloux, P. M. G. (2002). GnRH neuronal development: insights into hypogonadotrophic hypogonadism. Trends in Endocrinology & Metabolism, 13, 112–118.
   PubMed Web of Science ®Google Scholar
• Mantovani, G., Ozisik, G., Achermann, J. C., Romoli, R., Borretta, G., Persani, L., et al (2002). Hypogonadotrophic hypogonadism as a presenting feature of late-onset x-linked adrenal hypoplasia congenital. The Journal of Clinical Endocrinology & Metabolism, 87, 44–48.
   PubMed Web of Science ®Google Scholar
• Matsumoto, A. M., Snyder, P. J., Bhasin, S., Martin, K., Weber, T., Winters, S., et al (2009). Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long term treatment in azoospermic men with hypogonadotrophic hypogonadism. Fertility and Sterility, 92, 979–990.
   PubMed Web of Science ®Google Scholar
• McLachlan, R.I. (2000). The endocrine control of spermatogenesis. Baillière's Clinical Endocrinology and Metabolism, 14, 345–362.
   PubMed Web of Science ®Google Scholar
• McLachlan, R. I., O'Donnell, L., Stanton, P. G., Balourdos, G., Frydenberg, M., de Kretser, D. M., et al (2002). Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones and germ cell populations in normal young men. The Journal of Clinical Endocrinology & Metabolism, 87, 546–556.
   PubMed Web of Science ®Google Scholar
• Miyagawa, Y., Tsujimura, A., Matsumiya, K., Takao, T., Tohda, A., Kog, M., et al (2005). Outcome of gonadotrophin therapy for male hypogonadotrophic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. Journal of Urology, 173, 2072–2075.
   PubMed Web of Science ®Google Scholar
• Raivio, T., Falardeau, J., Dwyer, A., Quinton, R., Hayes, F. J., Hughes, V. A., et al (2007). Reversal of idiopathic hypogonadotrophic hypogonadism. New England Journal of Medicine, 357, 863–873.
   PubMed Web of Science ®Google Scholar
• Seminara, S. B., Hayes, F. J., Crowley, W. F. (1998). Gonadotrophin-releasing hormone deficiency in the human (idiopathic hypogonadotrophic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocrine Reviews, 19, 521–539.
   PubMed Web of Science ®Google Scholar
• Silveira, L. F. G., MacColl, G. S., Bouloux, P. M. G. (2002). Hypogonadotrophic hypogonadism. Seminars in Reproductive Medicine, 20, 327–338.
   PubMed Web of Science ®Google Scholar
• Swamy, G. K, Østbye, T., Skjærven, R. (2008). Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. The Journal of the American Medical Association, 12, 1429–1436.
   Google Scholar
• Tabarin, A., Achermann, J. C., Recan, D., Bex, V., Bertagna, X., Christin-Maitre, S. (2000). A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotrophic hypogonadism. The Journal of Clinical Investigation, 105, 321–328.
   PubMed Web of Science ®Google Scholar
• Van Dop, C., Burstein, S., Conte, F. A., Grumbach, M. M. (1987). Isolated gonadotrophin deficiency in boys: clinical characteristics and growth. The Journal of Pediatrics, 111, 684–692.
   PubMed Web of Science ®Google Scholar
• Warne, D. W., Decosterd, G., Okada, H., Yano, Y., Koide, N., Howles, C. M. (2009). A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotrophic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotrophin. Fertility and Sterility, 92, 594–604.
   PubMed Web of Science ®Google Scholar
• Zorn, B., Pfeifer, M., Virant-Klun, I., Meden-Vrtovec, H. (2005). Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism. International Journal of Andrology, 28, 202–207.
   PubMedGoogle Scholar
• Zitzman, M., Nieschlag, E. (2000). Hormone substitution in male hypogonadism. Molecular and Cellular Endocrinology, 161, 73–88.
   PubMed Web of Science ®Google Scholar